Psychosexual problems in persons with intersex-syndromes;Psychosexuelle probleme bei intersex-syndromen

Sexuologie

Volumn 12, Issue 1-2, 2005, Pages 31-59

  Bosinski, Hartmut A G ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

5 reductase 2 deficiency; Androgen insensivity; Congenital adrenal hyperplasia; Gender identity; Genital surgery; Gonadal dysgenesis

Indexed keywords

HORMONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE;

17BETA HYDROXYSTEROID DEHYDROGENASE DEFICIENCY; AGENESIS; ANDROGEN INSENSITIVITY SYNDROME; CHILD REARING; CLINICAL PRACTICE; CLITORIS; CLOACA; CLOACAL EXSTROPHY; CONGENITAL ADRENAL HYPERPLASIA; ENZYME DEFICIENCY; FEMALE; FERTILITY; GENDER IDENTITY; GENITAL MALFORMATION; GENOTYPE; GONADAL DYSGENESIS; HEALTH CARE PERSONNEL; HERMAPHRODITISM; HISTORY OF MEDICINE; HORMONAL THERAPY; HUMAN; MALE; MICROPENIS; OUTCOMES RESEARCH; PARENT; PSYCHOSEXUAL DISORDER; REVIEW; STEROID 5ALPHA REDUCTASE DEFICIENCY; UROLOGIC SURGERY; VAGINA RECONSTRUCTION; WELLBEING;

EID: 20844433240     PISSN: 09447105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (230)

1. Aartsen, E.J.; Snethlage, R.A.; Van Geel, A.N.; Gallee, M.P. (1994): Squamous cell carcinoma of the vagina in a male pseudohermaphrodite with 5alpha-reductase deficiency. INT J GYNECOL CANCER 4: 283-287.
2. Agate, R.A.; Grisham, W.; Wade, J.; Mann, S.; Wingfield, J.; Schanen, C.; Palotie, A.; Arnold, A.P. (2003); Neural, not gonadal, origin of brain sex differences in a gynandromorphic finch. PNAS 100: 4873-4878.
3. Aguilar-Diosdado, M.; Gavilan-Villarejo, I.; Escobar-Jimenez, L.; Beltran, J.; Giron, JA. (1995): Male pseudohermaphroditism with 5-alpha-reductase deficiency: report of two new familial cases. The importance of early diagnosis. J PEDIATR ENDOCRINOL METAB 8:67-71.
4. Ahmed, S.F.; Cheng, A.; Dovey, L.; Hawkins, J.R.; Martin, H.; Rowland, J.; Shimura, N.; Tait, A.D.; Hughes, I.A. (2000): Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J CLIN ENDOCRINOL METAB 85:658-65.
5. Akgun, S.; Ertel, N.H.; Imperato-McGinley, J.; Sayli, B.S.; Shackleton, C. (1986): Familial male pseudohermaphroditism due to 5-alpha-reductase deficiency in a Turkish village. AM J MED 81: 267-74.
6. Al-Attia, H.M. (1996): Gender identity and role in a pedigree of Arabs with intersex due to 5 alpha reductase-2 deficiency. PSYCHONEUROENDOCRINOLOGY 21:651-7.
7. Al-Bassam, A.; Gado, A. (2004): Feminizing genital reconstruction: experience with 52 cases of ambiguous genitalia. EUR J PEDIATR SURG 14:172-8.
8. Alderson, J.; Madill, A.; Balen, A. (2004): Fear of devaluation: understanding the experience of intersexed women with androgen insensitivity syndrome. BR J HEALTH PSYCHOL 9:81-100.
9. Alizai, N.K.; Thomas, D.F.; Lilford, R.J.; Batchelor, A.G.; Johnson, N. (1999): Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty? J UROL 161:1588-91.
10. Alvarez-Nava, F.; Gonzalez, S.; Soto, S.; Pineda, L.; Morales-Machin, A. (1999): Mixed gonadal dysgenesis: a syndrome of broad clinical, cytogenetic and histopathologic spectrum. GENET COUNS 10:233-43.
11. Andersson, S.; Geissler, W.M.; Wu, L.; Davis, D.L.; Grumbach, M.M.; New, M.I.; Schwarz, H.P.; Blethen, S.L.; Mendonca, B.B.; Bloise, W.; Witchel, S.F.; Cutler, G.B.; Griffin, J.E.; Wilson, J.D.; Russell, D.W. (1996): Molecular genetics and pathophysiology of 17b-hydroxysteroid dehydrogenase 3 deficiency. J CLIN ENDOCRINOL METABOL 81: 139-136.
12. Arnold, A.P.; Xu, J.; Grisham, W.; Chen, X.; Kim, Y.H.; Itoh, Y. (2003): Sex chromosomes and brain sexual differentiation. ENDOCRINOLOGY 145: 1057-1062
13. Bailez, M.M.; Gearhart, J.P.; Migeon, C.; Rock, J. (1992): Vaginal reconstruction after initial construction of the external genitalia in girls with salt-wasting adrenal hyperplasia. J UROL 148: 680-2.
14. Baker Towell, D.M.; Towell, A.D. (2003): A preliminary investigation into quality of life, psychological distress and social competence in children with cloacal exstrophy. J UROL 169: 1850-3.
15. Barbin, H.; Foucault, M. (1998): Über Hermaphrodismus. Frankfurt; M.: Edition Suhrkamp.
16. Baskin, L.S. (2002): Anatomical studies of the fetal genitalia: surgical reconstructive implications. ADV EXP MED BIOL 511: 239-49.
17. Baskin, L.S. (2004): Anatomical studies of the female genitalia: surgical reconstructive implications. J PEDIATR ENDOCRINOL METAB 17: 581-7.
18. Baumgartner-Parzer, S.M.; Nowotny, P.; Heinze, G.; Waldhäusl, W.; Vierhapper, H. (2005): Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle european population. J CLIN ENDOCRINOL METABOL 90: 775-778.
19. Beh, H.G.; Diamond, M. (2000): Surgical Treatment of Infants with Ambiguous Genitalia: Deficiencies in the Standard of Care and Informed Consent. Michigan J Gender & Law 7: 1-63.
20. Berenbaum, S.A. (2003): Management of children with intersex consitions: Psychological and methodological perspectives. GROWTH GENTECIS & HORMONES 19: 1-6.
21. Berenbaum, S.A.; Bailey, J.M. (2003): Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia. J CLIN ENDOCRINOL METAB 88: 1102-6.
22. Berenbaum, S.A.; Duck, S.C.; Bryk, K. (2000): Behavioral effects of prenatal versus postnatal androgen excess in children with 21-hydroxylase- deficient congenital adrenal hyperplasia. J CLIN ENDOCRINOL METABOL 85: 727-733.
23. Berenbaum, S.A.; Korman Bryk, K.; Duck, S.C.; Resnick, S.M. (2004): Psychological adjustment in children and adults with congenital adrenal hyperplasia. J PEDIATR 144:741-6.
24. Bin-Abbas, B.; Conte, F.A.; Grumbach, M.M.; Kaplan, S.L. (1999): Congenital hypogonadotropic hypogonadism and micropenis: Effect of testosterone treatment on adult penile size why sex reversal is not indicated. J PEDIATR 134: 579-83.
25. Birnbacher, R.; Marberger, M.; Weissenbacher, G.; Schober, E.; Frisch, H. (1999): Gender identity reversal in an adolescent with mixed gonadal dysgenesis. J PEDIATR ENDOCRINOL METAB 12: 687-90.
26. Blackless, M.; Charuvastra, A.; Derryck, A.; Fausto-Sterling, A.; Lauzanne, K.; Lee, E. (2000): How sexually dimorphic are we? Review and synthesis. AM J HUMAN BIOLOGY 12: 151-166.
27. Boehmer, A.L.; Brinkmann, A.O.; Sandkuijl, L.A.; Halley, D.J.; Niermeijer, M.F.; Andersson, S.; de Jong, F.H.; Kayserili, H.; de Vroede, M.A.; Otten, B.J.; Rouwe, C.W.; Mendonca, B.B.; Rodrigues, C.; Bode, H.H.; de Ruiter, P.E.; Delemarre-van de Waal, H.A.; Drop, S.L. (1999); 17beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J CLIN ENDOCRINOL METAB 84: 4713-21.
28. Boehmer, A.L.; Brinkmann, O.; Bruggenwirth, H.; van Assendelft, C.; Otten, B.J.; Verleun-Mooijman, M.C.; Niermeijer, M.F.; Brunner, H.G.; Rouwe, C.W.; Waelkens, J.J.; Oostdijk, W.; Kleijer, W.J.; van der Kwast, T.H.; de Vroede, M.A.; Drop, S.L. (2001 a): Genotype versus phenotype in families with androgen insensitivity syndrome. J CLIN ENDOCRINOL METAB 86: 4151-60.
29. Boehmer, A.L.; Nijman, R.J.; Lammers, B.A.; de, Coninck, S.J.; Van Hemel, J.O.; Themmen, A.P.; Mureau, M.A.; de Jong, F.H.; Brinkmann, A.O.; Niermeijer, M.F.; Drop, S.L. (2001 b): Etiological studies of severe or familial hypospadias. J UROL 165: 1246-54.
30. Borer, JG.; Nitti, VW.; Glassberg, KI. (1995): Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism. J UROL 153: 1267-73.
31. Bosinski, H.A.G. (2000 a): Determinanten der Geschlechtsidentität- Neue Befunde zu einem alten Streit. SEXUOLOGIE 7: 96-140.
32. Bosinski, H.A.G. (2000 b): Frau-zu-Mann-Transsexualismus: Ein biopsychosozialer Erklärungsansatz. HUMANONTOGENETIK 2: 69-86.
33. Bosinski, H.A.G. (2001): Psychosexuelle Probleme bei Störungen der somatosexuellen Entwicklung. MED GEN 13: 42-45.
34. Bosinski, H.A.G. (2003): Diagnostische und arztrechtliche Probleme bei transsexuellen Geschlechtsidentitätsstörungen. Urologe [A] 42:709-721.
35. Boudon, C.; Lumbroso, S.; Lobaccaro, J.M.; Szarras-Czapnik, M.; Romer, T.E.; Garandeau, P.; Montoya, P.; Sultan, C. (1995): Molecular study of the 5a-reductase type 2 gene in three european families with 5a-reductase deficiency. J CLIN ENDOCRINOL METABOL 80: 2149-2153.
36. Bouvattier, C.; Carel, J.C.; Lecointre, C.; David, A.; Sultan, C.; Bertrand, A.M.; Morel, Y.; Chaussain, J.L. (2002): Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J CLIN ENDOCRINOL METAB 87:29-32.
37. Brinkmann, A.O. (2001): Molecular basis of androgen insensitivity. MOL CELL ENDOCRINOL 179:105-9.
38. British Association of Paediatric Surgeons (BAPS) (2001): Statement of the Working Party (Rangecroft, L.; Brain, C.; Creighton, S.; Di Ceglie, D.; Ogilvy-Stuart, A.; Malone, P; Turnock, R.) on the Surgical Management of Children Born with Ambiguous Genitalia. http://www.baps.org. uk;documents;Intersex%20statement.htm
39. Byun, J.S.; Cho, B.C.; Baik, B.S. (1994): Results of one-stage penile reconstruction using an innervated radial osteocutaneous flap. J RECONSTR MICROSURG 10: 321-31.
40. Cai, L.Q.; Zhu, Y.S.; Katz, M.D.; Herrera, C.; Baez, J.; DeFillo-Ricart, M.; Shackleton, C.H.; Imperato-McGinley, J. (1996): 5-alpha-reductase-2 gene mutations in the Dominican Republic. J CLIN ENDOCRINOL METAB 81:1730-5.
41. Can, S.; Zhu, Y.S.; Cai, L.Q.; Ling, Q.; Katz, M.D.; Akgun, S.; Shackleton, C.H.L.; Imperato-McGinley, J. (1998): The Identification of 5a-reductase-2 and 17β-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. CLIN ENDOCRINOL METABOL 83: 560-569.
42. Canto, P.; Vilchis, F.; Chavez, B.; Mutchinick, O.; Imperato-McGinley, J.; Perez-Palacios, G.; Ulloa-Aguirre, A.; Mendez, J.P. (1997): Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency. CLIN ENDOCRINOL (Oxf) 46:155-60.
43. Cantu, J.M.; Corona-Rivera, E.; Diaz, M.; Medina, C.; Esquinca, E.; Cortes-Gallegos, V.; Vaca, G.; Hernandez, A. (1980): Post-pubertal female psychosexual orientation in incomplete male pseudohermaphroditism type 2 (5 alpha-reductase deficiency). ACTA ENDOCRINOL (Copenh) 94:273-9.
44. Chase, C. (1999): Rethinking treatment for ambiguous genitalia. PEDIATRIC NURSING 25: 451-455.
45. Chavez, B.; Mendez, JP.; Ulloa-Aguirre, A.; Larrea, F.; Vilchis, F. (2001): Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome. J HUM GENET 46: 560-5.
46. Chávez, B.; Valdez, E.; Vilchis, F. (2000): Uniparental disomy in steroid 5a-reductase-2-deficiency. J CLIN ENDOCRINOL METABOLOL 85: 3147-3150.
47. Ciftci, A.O.; Senocak, M.E.; Buyukpamukcu, N. (1995): Male gender assignment in penile agenesis: a case report and review of the literature. J PEDIATR SURG 30: 1358-60.
48. Codner, E.; Okuma, C.; Iniguez, G.; Boric, M.A.; Avila, A.; Johnson, M.C.; Cassorla, F.G. (2004): Molecular study of the 3 beta-hydroxysteroid dehydrogenase gene type II in patients with hypospadias. J CLIN ENDOCRINOL METAB 89: 957-64.
49. Colapinto, J. (2000): As Nature Made Him: The Boy Who Was Raised As a Girl. New York: HarperCollins.
50. Corrall, R.J.; Wakelin, K.; O'Hare, J.P.; O'Brien, I.A.; Ishmail, A.A.; Honour, J. (1984): 5 alpha-reductase deficiency: diagnosis via abnormal plasma levels of reduced testosterone derivatives. ACTA ENDOCRINOL (Copenh) 107: 538-43.
51. Creighton, S.M.; Minto, C.L. (2001): Managing intersex. BR MED J 323: 1264-1265.
52. Creighton, S.M.; Minto, C.L.; Liao, L.M.; Alderson, J.; Simmonds, M. (2004): Meeting between experts: evaluation of the first UK forum for lay and professional experts in intersex. PATIENT EDUC COUNS 54: 153-7.
53. Creighton, S.M.; Minto, C.L.; Steele, S.J. (2001): Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. LANCET 358: 124-5.
54. Crouch, N.S.; Creighton, S.M. (2004): Minimal surgical intervention in the management of intersex conditions. J PEDIATR ENDOCRINOL METAB 17: 1591-6.
55. Crouch, N.S.; Minto, C.L.; Laio, L.M.; Woodhouse, C.R.; Creighton, S.M. (2004): Genital sensation after feminizing genitoplasty for congenital adrenal hyperplasia: A pilot study. BJU INT 93: 135-8.
56. Dasgupta, R.; Schnitzer, J.J.; Hendren, W.H.; Donahoe, P.K. (2003): Congenital adrenal hyperplasia: surgical considerations required to repair a 46,XX patient raised as a boy. J PEDIATR SURG 38: 1269-73.
57. De Fontaine, S.; Lorea, P.; Wespes, E.; Schulman, C.; Goldschmidt, D. (2001): Complete phalloplasty using the free radial forearm flap for correcting micropenis associated with vesical exstrophy. J UROL 166:597-9.
58. Dessouky, N.M. (2003) Gender assignment for children with intersex problems: An Egyptian perspective. SAUDI MED J 24(5 Suppl): 51-2.
59. Dewing, P.; Shi, T.; Horvath, S.; Vilain, E. (2003): Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation. BRAIN RES MOL BRAIN RES 21:82-90.
60. Diamond, M. (1982): Sexual identity, monozygotic twins reared in discordant sex roles and a BBC follow-up. Brief communication. ARCH SEX BEHAV 11: 181-186.
61. Diamond, M.; Yates, A. (Eds.) (2004): Sex and gender. CHILD ADOLESC PSYCHIATR CLIN N AM Vol. 13, Number 3.
62. Diamond, M.; Sigmundson, K. (1997): Mangement of intersexuality. Guidelines for dealing with persons with ambiguous genitalia. ARCH PEDIATR ADOLESC MED 151: 1046-1050.
63. Diamond, M.; Watson, L.A. (2004): Androgen insensitivity syndrome and Klinefelter's syndrome: sex and gender considerations. CHILD ADOLESC PSYCHIATR CLIN N AM 13: 623-40.
64. Dittmann, R.W.; Kappes, M.H.; Kappes, M.E. (1992): Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. PSYCHONEUROENDOCRINOLOGY 17: 1-18.
65. Dreger, A.D. (1998 a): Hermaphrodites and the medical invention of sex. Cambridge, London: Harvard Univ Press.
66. Dreger, A.D. (1998 b): "Ambiguous sex" - or ambivalent medicine? Ethical issues in the treatment of intersexuality. HASTINGS CENTER REPORT 28: 24-36.
67. Duncan, S.L.; Page, K.B.; Rodgers, D.A. (1997): 17 beta-hydroxy-steroid dehydrogenase deficiency with minimal virilization and spontaneous reduction of serum androgens to normal female levels. CLIN ENDOCRINOL (Oxf) 46: 369-72.
68. Eckstein, B.; Cohen, S.; Farkas, A.; Rösler, A (1989): The nature of the defect in familial male pseudohermaphroditism in Arabs of Gaza. J CLIN ENDOCRINOL METAB 68: 477-485.
69. Elsas, L.J.; Ljungqvist, A.; Ferguson-Smith, M.A.; Simpson, J.L.; Genel, M.; Carlson, A.S.; Ferris, E.; de la Chappelle, A.; Ehrhardt, A.A. (2000): Gender verification of female athletes. GENET MED 2: 249-254.
70. Eroglu, E.; Tekant, G.; Gundogdu, G.; Emir, H.; Ercan, O.; Soylet, Y.; Danismend, N. (2004): Feminizing surgical management of intersex patients. PEDIATR SURG INT 20: 543-7.
71. Evans, J.A.; Erdile, L.B.; Greenberg, C.R.; Chudley, A.E. (1999): Agenesis of the penis: Patterns of associated malformations. AM J MEDIC GENETIC 84: 47-55.
72. Farkas, A.; Rösler; A. (1993): Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency. EUR J PEDIATR 152: S88-90.
73. Fausto-Sterling, A. (2000): The five sexes, revisited. Sciences (New York) 40: 18-23.
74. Ferraz, L.F.; Mathias, Baptista, M.T.; Maciel-Guerra, A.T.; Junior, G.G.; Hackel, C. (1999): New frameshift mutation in the 5alpha-reductase type 2 gene in a Brazilian patient with 5alpha-reductase deficiency. AM J MED GENET 87: 221-5.
75. Fisher, J.S. (2004): Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. REPRODUCTION 127: 305-15.
76. Forest, M.G. (2004): Recent advances in the diagnosis and management of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. HUM REPROD 10: 469-485.
77. Forest, M.G.; Nicolino, M.; David, M.; Morel, Y. (2004): The virilized female: endocrine background. BJU INT 93 (Suppl. 3): 35-43.
78. Ford, G.; Falchetti, A.; Santoro, S.; Davis, D.L.; , Wilson, J.D.; Russell, D.W. (1996): Steroid 5 alpha-reductase 2 deficiency: virilization in early infancy may be due to partial function of mutant enzyme. CLIN ENDOCRINOL 44: 477-482.
79. Gearhart, J.P.; Burnett, A.; Owens, J.H. (1995): Measurement of pudendal evoked potentials during feminising genitoplasty: Technique and applications. J UROL 153: 486-7.
80. Genel, M. (2000): Gender Verification No More? Medscape Women's Health 5(3): http://womenshealth.medscape.com; Medscape; womenshealth; journal; public; archive; 2000; toc-0503.html.
81. Giwercman, Y.L.; Ivarsson, S.A.; Richthoff, J.; Lundin, K.B.; Giwercman, A. (2004): A novel mutation in the D-box of the androgen receptor gene (S597R) in two unrelated individuals Is associated with both normal phenotype and severe PAIS. HORM RES 61:58-62.
82. Giwercman, Y.L.; Nikoshkov, A.; Bystrom, B.; Pousette, A.; Arver, S.; Wedell, A. (2001): A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility. CLIN ENDOCRINOL (Oxf) 54: 827-34.
83. Gooren, L.J.G.; Cohen-Kettenis, P.T. (1991): Development of male gender identity; role and a sexual orientation towards women in a 46,XY subject with incomplete form of the androgen insensivity syndrome. ARCH SEX BEHAV 20: 459-470.
84. Gottlieb, B.; Beitel, L.K.; Wu, J.H.; Trifiro, M. (2004): The androgen receptor gene mutations database (ARDB): 2004 update. HUM MUTAT 23: 527-33.
85. Graziano, K.; Teitelbaum, D.H.; Hirschl, R.B.; Coran, A.G. (2002): Vaginal reconstruction for ambiguous genitalia and congenital absence of the vagina: a 27-year experience. J PEDIATR SURG 37: 955-60.
86. Gregory, J.W.; Aynsley-Green, A.; Evans, B.A.; Hughes, I.A.; Werder, E.A.; Zachmann, M. (1993): Deficiency of 17-ketoreductase presenting before puberty. HORM RES 40: 145-8.
87. Gupta, D.K.; Menon, P.S. (1997): Ambiguous genitalia - an Indian perspective. INDIAN J PEDIATR 64: 189-94.
88. Hall, C.M.; Jones, J.A.; Meyer-Bahlburg, H.F.L.; Dolezal, C.; Coleman, M.; Foster, P.; Price, D.A.; Clayton, P.E. (2004): Behavioral and physical masculinization are related to genotype in girls with congenital adrenal hyperplasia (CAH). J CLIN ENOCRINOL METABOLISM 89: 419-424.
89. Hannema, S.E.; Scott, I.S.; Hodapp, J.; Martin, H.; Coleman, N.; Schwabe, J.W.; Hughes, I.A. (2004): Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome. J CLIN ENDOCRINOL METAB 89: 5815-22.
90. Hausman, B.L. (2000): Do Boys have to be boys? Gender, narrativity, and the John; Joan case. NWSA J 12: 114-138.
91. Hedia, S.; Mohamed, S.; Insaf, H.A.; Houda, G.; Yamina, F.; Myrvat, K.; Maria, H.; Ali, H. (2001): [Male pseudo-hermaphroditism due to partial 5 alpha-reductase deficiency, a case report] TUNIS MED 79: 261-5.
92. Herdt, G.H.; Davidson, J. (1988): The "Sambia Turnim Man": Sociocultural and clinical aspects of gender formation in male pseudohermaphrodites with 5alpha-reductase deficiency in Papua New Guinea. ARCH SEX BEHAV 17: 33-56.
93. Hines, M. (2003): Sex steroids and human behavior: Prenatal androgen exposure and sex-typical play behavior in children. ANN N Y ACAD SCI 1007: 272-82.
94. Hines, M.; Ahmed, S.F.; Hughes, I.A. (2003): Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. ARCH SEX BEHAV 32: 93-101.
95. Hiort, O.; Holterhus, P.M.; Sinnecker, G.H.G.; Krus, K. (1999): Androgenresistenzsyndrome - klinische und molekulare Grundlagen. DT ÄRZTEBLATT 96, H 11: A-686-692.
96. Hiort, O.; Schutt, S.M.; Bals-Pratsch, M.; Holterhus, P.M.; Marschke, C.; Struve, D. (2002): A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency. INT J ANDROL 25: 55-8.
97. Hiort, O.; Willenbring, H.; Albers, N.; Hecker, W.; Engert, J.; Dibbelt, L.; Sinnecker, GH. (1996): Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency. EUR J PEDIATR 155: 445-51.
98. Hochberg, Z.; Chayen, R.; Reiss, N.; Falik, Z.; Makler, A.; Munichor, M.; Farkas, A.; Goldfarb, H.; Ghana, N.; Hiort, O. (1996): Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency. J CLIN ENDOCRINOL METAB 81: 2821-7.
99. Holterhus, P.M.; Hiort, O.; Demeter, J.; Brown, P.O.; Brooks, J.D. (2003): Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. GENOME BIOL 4: R37.
100. Hooper, H.T.; Figueiredo, B.C.; Pavan-Senn, C.C.; De Lacerda, L.; Sandrini, R.; Mengarelli, J.K.; Japp, K.; Karaviti, L.P. (2004): Concordance of phenotypic expression and gender identity in a large kindred with a mutation in the androgen receptor. CLIN GENET 65: 183-90.
101. Hurwitz, R.S.; Manzoni, G.A.; Ransley, P.O.; Stephens, F.D. (1987): Cloacal exstrophy. A report of 34 cases. J UROL 138: 1060-4.
102. Husmann, D.A.; McLorie, G.A.; Churchill, B.M. (1989): Phallic reconstruction in cloacal exstrophy. J UROL 142: 563-4.
103. Imperato-McGinley, J. (2002): 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. ADV EXP MED BIOL 511: 121-31; discussion 131-4.
104. Imperato-McGinley, J.; Miller, M.; Wilson, J.D.; Peterson, R.E.; Shackleton, C.; Gajdusek, D.C. (1991): A cluster of male pseudohermaphrodites with 5-alpha-reductase deficiency in Papua New Guinea. CLIN ENDOCRINOL (Oxf) 34(4): 293-8.
105. Imperato-McGinley, J.; Peterson, R.E.; Gautier, T.; Sturla, E. (1974): Steroid 5alpha-reductase deficiency in man: An inherited form of male pseudohermaphroditism. SCIENCE 186: 1213-1243.
106. Imperato-McGinley, J.; Peterson, R.E.; Leshin, M.; Griffin, J.E.; Cooper, G.; Draghi, S.; Berenyi, M.: Wilson, J.D. (1980): Steroid Salpha-reductase deficiency in a 65-year old male pseudohermaphrodite: The natural history, ultrastructure of the testis and evidence for inherite enzyme heterogenity. J CLIN ENDOCRINOL METABOL 50: 15-22.
107. Imperato-McGinley, J.; Peterson, R.E.; Stoller, R.; Goodwin, W.E. (1979): Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J CLIN ENDOCRINOL METAB 49: 391-5.
108. Imperato-McGinley, J.; Zhu, Y.S. (2002): Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. MOL CELL ENDOCRINOL 198: 51-9.
109. Jensen, A.; Grewal, H.; Dean, G.; Rezvani, I. (2003): Pediatric surgical images: mixed gonadal dysgenesis. J PEDIATR SURG 38: 988-9.
110. Jones, H.W. Jr.; Park, I.J.; Rock, J.A. (1978): Technique of surgical sex reassignment for micropenis and allied conditions. AM J OBSTET GYNECOL 132: 870-7.
111. Kaefer, M.; Diamond, D.; Hendren, W.H.; Vemulapalli, S.; Bauer, S.B.; Peters, C.A.; Atala, A.; Retik, A.B. (1999): The incidence of intersexuality in children with cryptorchidism and hypospadias: stratification based on gonadal palpability and meatal position. J UROL 162: 1003-1006.
112. Kipnis, K.; Diamond, M. (1998): Pediatric ethics and the surgical assignment of sex. J CLIN ETHICS 9: 398-410.
113. Kohler, B.; Lumbroso, S.; Leger, J.; Audran, F.; Grau, ES.; Kurtz, F.; Pinto, G.; Salerno, M.; Semitcheva, T; Czernichow, P.; Sultan, C. (2005): Androgen insensitivity syndrome: Somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J CLIN ENDOCRINOL METAB 90: 106-11.
114. Krege, S.; Walz, KH.; Hauffa, BP.; Korner, I.; Rubben, H. (2000): Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty. BJU INT 86: 253-8.
115. Kuhnle, U.; Krahl, W. (2002): The impact of culture on sex assignment and gender development in intersex patients. PERSPECTIVES IN BIOLOGY & MEDICINE 45: 85-103.
116. Kuttenn, F; Mowszowicz, I.; Wright, F.; Baudot, N.; Jaffiol, C.; Robin, M.; Mauvais-Jarvis, P. (1979): Male pseudohermaphroditism: a comparative study of one patient with 5 alpha-reductase deficiency and three patients with the complete form of testicular feminization. J CLIN ENDOCRINOL METAB 49: 861-5.
117. Labrie, F.; Sugimoto, Y.; Luu-The, V.; Simard, J.; Lachance, Y.; Bachvarov, D.; Leblanc, G.; Durocher, F.; Paquet, N. (1992): Structure of human type II 5 alpha-reductase gene. ENDOCRINOLOGY 131: 1571-1573.
118. Lalau Keraly, J.; Chaussain, J.L.; Job, J.C. (1985): Mixed gonadal dysgenesis. Apropos of a series of 21 cases. ARCH FR PEDIATR 42: 169-73.
119. Lawson Wilkins Pediatric Endocrine Society (LWPES); European Society for Peadiatric Endocrinology (ESPE) (2002): Joint CAH working group (Clayton, P.E.; Miller, W.L.; Oberfield, S.E.; Ritzen, E.M.; Sippell, W.O.; Speiser, P.W.) (2002):Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. HORM RES 58: 188-95.
120. Lee, P.A.; Witchel, S.F. (2002): Genital surgery among females with congenital adrenal hyperplasia: changes over the past five decades. J PEDIATR ENDOCRINOL METAB 15: 1473-7.
121. Lindqvist, A.; Hughes, I.A.; Andersson, S. (2001): Substitution mutation C268Y causes 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J CLIN ENDOCRINOL METAB 86:921-3.
122. Lund, D.P.; Hendren, W.H. (2001): Cloacal exstrophy: a 25-year experience with 50 cases. J PEDIATR SURG 36: 68-75.
123. May, B.; Boyle, M.; Grant, D. (1996): A comparative study of sexual experiences: women with diabetes and women with congenital adrenal hyperplasia. J HEALTH PSYCHOL 1: 153-170.
124. Mazen, I.; Hafez, M.; Mamdouh, M.; Sultan, C.; Lumbroso, S. (2003): A novel mutation of the 5alpha-reductase type 2 gene in two unrelated Egyptian children with ambiguous genitalia. J PEDIATR ENDOCRINOL METAB 16:219-24.
125. Mazen, I.; Gad, YZ.; Hafez, M.; Sultan, C.; Lumbroso, S. (2003): Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated egyptian children with suspected 5alpha-reductase deficiency, prevalence of the G34R mutation. CLIN ENDOCRINOL (Oxf) 58:627-31.
126. Mazen, I.; Lumbroso, S.; Abdel Ghaffar, S.; Salah, N.; Sultan, C. (2004): Mutation of the androgen receptor (R840S) in an Egyptian patient with partial androgen insensitivity syndrome: review of the literature on the clinical expression of different R840 substitutions. J ENDOCRINOL INVEST 27:57-60.
127. Mazur, T.; Sandberg, D.E.; Perrin, M.A.; Gallagher, J.A.; MacGilliivray, M.H. (2004): Male pseudohermaphroditism: Long-term quality of life outcome in five 46,XY individuals reared female. J PEDIATR ENDOCRINOL METAB 17: 809-23.
128. McDonald, M.T.; Flejter, W.; Sheldon, S.; Putzi, M.J.; Gorski, J.L. (1997): XY sex reversal and gonadal dysgenesis due to 9p24 monosomy. AM J MED GENET 73: 321-326.
129. Melo, K.F.; Mendonca, B.B.; Billerbeck, A.E.; Costa, E.M.; Inacio, M.; Silva, F.A.; Leal, A.M.; Latronico, A.C.; Arnhold, I.J. (2003): Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J CLIN ENDOCRINOL METAB 88: 3241-50.
130. Melton, L. (2001): New perspectives on the management of intersex. LANCET 357: 2110.
131. Mendez, J.P.; Ulloa-Aguirre, A.; Imperato-McGinley, J.; Brugmann, A.; Delfin, M.; Chavez, B.; Shackleton, C.; Kofman-Alfaro, S.; Perez-Palacios, G. (1995): Male pseudohermaphroditism due to primary 5 alpha-reductase deficiency: variation in gender identity reversal in seven Mexican patients from five different pedigrees. J ENDOCRINOL INVEST 18: 205-13.
132. Mendonca, B.B.; Inacio, M.; Amhold, I.J.; Costa, E.M.; Bloise, W.; Martin, R.M.; Denes, F.T.; Silva, F.A.; Andersson, S.; Lindqvist, A.; Wilson, J.D. (2000): Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. MEDICINE (Baltimore) 79: 299-309.
133. Mendonca, B.B.; Inacio, M.; Costa, E.M.; Arnhold, I.J.; Silva, F.A.; Nicolau, W.; Bloise, W.; Russel, D.W.; Wilson, J.D. (1996): Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management. MEDICINE (Baltimore) 75: 64-76.
134. Meyer-Bahlburg, H.F.L. (1999): What causes low rates of child-bearing in congenital adrenal hyperplasia (CAH)? J CLIN ENDOCRINOL METABOLOL 84: 1844-1847.
135. Meyer-Bahlburg, H.F.L. (2001): Gender and sexuality in classic congenital adrenal hyperplasia (CAH). ENDOCRINOL METABOLISM CLINICS NORTH AMERICA 30: 155-171.
136. Meyer-Bahlburg, H.F.L. (2002): Gender assignment and reassignment in intersexuality: controversies, data, and guidelines for research. ADV EXP MED BIOL 511: 199-223.
137. Meyer-Bahlburg, H.F.L.; Blizzard, R.M. (2004): Conference proceedings: Research on intersex. ENDOCRINOLOGIST 14: 59-69.
138. Meyer-Bahlburg, H.F.L.; Dolezal, C.; Baker, S.W.; Carlson, A.D.; Obeid, J.S.; New, M.I. (2004): Prenatal androgenization affects gender-related behavior but not gender identity in 5-12-year-old girls with congenital adrenal hyperplasia. ARCH SEX BEHAV 33:97-104.
139. Meyer-Bahlburg, H.F.L.; Gruen, R.S.; New, M.I.; Bell, J.J.; Morishima, A.; Shimshi, M.; Bueno, Y.; Vargas, I.; Baker, S.W. (1996): Gender change from female to male in classical congenital adrenal hyperplasia (CAH). HORMONES & BEHAVIOR 30: 319-332.
140. Migeon, C.J.; Wisniewski, A.B.; Brown, T.R.; Rock, J.A.; Meyer-Bahlburg, H.F.; Money, J.; Berkovitz, G.D. (2002b): 46,XY intersex individuals: phenotypic and etiologic classification, knowledge of condition, and satisfaction with knowledge in adulthood. PEDIATRICS 110(3):e32.
141. Migeon, C.J.; Wisniewski, A.B.; Gearhart, J.P.; Meyer-Bahlburg, H.F.; Rock, J.A.; Brown, T.R.; Casella, S.J.; Maret, A.; Ngai, K.M.; Money, J.; Berkovitz, G.D. (2002a): Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: Long-term medical, surgical, and psychosexual outcome. PEDIATRICS 110(3): e31
142. Minto, C.L.; Liao, K.L.; Conway, G.S.; Creighton, S.M. (2003): Sexual function in women with complete androgen insensitivity syndrome. FERTIL STERIL 80: 157-64.
143. Minto, C.L.; Liao, L-M.; Woodhouse, C.R.J.; Ransley, P.O.; Creighton, S.M. (2003): The effect of clitorial surgery on sexual outsome in individuals who have intersex conditions with ambiguous genitalia: A cross-sectional study. LANCET 361: 1252-1257.
144. Mitchell, M.E.; Plaire, C. (2002): Management of cloacal exstrophy. ADV EXP MED BIOL 511: 267-270; discussion 270-273.
145. Moghrabi, N.; Hughes, I.A.; Dunaif, A.; Andersson, S. (1998): Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3). J CLIN ENDOCRINOL METAB 83: 2855-60.
146. Money, J. (1987): Psychological considerations in patients with ambisexual development. SEMINARS REPRODUCT ENDOCRINOL 5: 307-313.
147. Money, J. (1988): Gay, straight, and In-between. The sexology of erotic orientation. New York: Oxford University Press.
148. Money, J. (1991): Biographies of gender and hermaphroditism in paired comparison. Clinical supplement to the Handbook of Sexology. Amsterdam: Elsevier.
149. Money, J.; Daléry, J. (1976): Iatrogenic homosexuality, gender identity in seven 46,XX chromosomal females with hyperadrenocortical hermaphroditism born with a penis, three reared as boys, four reared as girls. J HOMOSEX 1: 357-71.
150. Money, J.; Ehrhardt, A.A. (1975): Männlich - Weiblich: Die Entstehung der Geschlechtsunterschiede. Reinbeck:Rowohlt-Taschenbuch.
151. Money, J.; Hampson, J.G.; Hampson, J.L. (1955): An examination of some basic sexual concepts: The evidence of human hermaphroditism. BULL JOHNS HOPKINS HOSP 97: 301-319.
152. Money, J.; Schwartz, M.; Lewis, V.G. (1984): Adult erotosexual status and fetal hormonal masculinization and demasculinization; 46,XX congenital virilizing adrenal hyperplasia and 46,XY androgen-insensivity syndrome compared. PSYCHONEUROENDOCRINOLOGY 9: 405-414.
153. Morel, Y.; Rey, R.; Teinturier, C.; Nicolino, M.; Michel-Calemard, L.; Mowszowicz, I.; Jaubert, F.; Fellous, M.; Chaussain, J.L.; Chatelain, P.; David, M.; Nihoul-Fekete, C.; Forest, MG.; Josso, N. (2002): Aetiological diagnosis of male sex ambiguity: A collaborative study. EUR J PEDIATR 161: 49-59.
154. Mouriquand, P.D.E. (2004): Possible determinants of sexual identity: How to make the least bad choice in children with ambiguous genitalia. BJU INT 93 (Suppl. 3): 1-2.
155. Mulaikal, R.M.; Migeon, C.J.; Rock, J.A. (1987): Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N ENGL J MED 316: 178-182.
156. Mulaisho, C.; Taha, S.A.; Imperato-McGinley, J. (1990): Male pseudohermaphroditism due to deficiency of steroid 5a reductase enzyme. SAUDI MED J 11: 71-73.
157. Nanni, L.; D'Urzo, C.; Pintus, C.; Riccipetitoni, G.; Perrelli, L. (2003): Laparoscopic approach to mullerian derivatives in a male with mixed gonadal dysgenesis. SURG LAPAROSC ENDOSC PERCUTAN TECH 13: 128-32.
158. Ng, WK.; Taylor, NF.; Hughes, IA.; Taylor, J.; Ransley, PG.; Grant, DB. (1990): 5 alpha-reductase deficiency without hypospadias. ARCH DIS CHILD 65: 1166-7.
159. Nicolino, M.; Bendelac, N.; Jay, N.; Forest, M.G.; David, M. (2004): Clinical and biological assessments of the undervirilized male. BJU INT 93 (Suppl. 3): 20-25.
160. Nihoul-Fékété, C. (2003):Surgical management of the intersex patient: an overview in 2003 (The Isabel Forshall lecture). J PEDIATR SURG 39: 144-5.
161. Nordenskjöld, A.; Magnus, O.; Aagenaes, O.; Knudtzon, J. (1998): Homozygous mutation (A228T) in the 5alpha-reductase type 2 gene in a boy with 5alpha-reductase deficiency: genotype-phenotype correlations. AM J MED GENET 80: 269-72.
162. Nordenström, A.; Servin, A.; Bohlin, G.; Larsson, A.; Wedell, A.
163. Ocal, G.; Adiyaman, P.; Berberoglu, M.; Cetinkaya, E.; Akar, N.; Uysal, A.; Duman, T.; Evliyaoglu, O.; Aycan, Z.; Lumbroso, S.; Sultan, C. (2002): Mutations of the 5alpha-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J PEDIATR ENDOCRINOL METAB 15:411-21.
164. Oesch, I.L.; Pinter, A.; Ransley, P.G. (1987): Penile agenesis: A report of six cases. J PEDIATR SURG 22: 172-4.
165. Ozbey, H.; Darendeliler, F.; Kayserili, H.; Korkmazlar, U.; Salman, T. (2004): Gender assignment in female congenital adrenal hyperplasia: A difficult experience. BJU INT 94: 388-91.
166. Phillip, M.; De Boer, C.; Pilpel, D.; Karplus, M.; Sofer, S. (1996): Clitoral and penile sizes of full term newborns in two different ethnic groups. J PEDIATR ENDOCRINOL METAB 9: 175-9.
167. Phornphutkul, C.; Fausto-Sterling, A.; Gruppuso, P.A. (2000): Gender self-reassignment in an XY adolescent female born with ambiguous genitalia. PEDIATRICS 106: 135-137.
168. Pohlandt, F.; Kühn, H.; Teller, W.; Thomä, H. (1974): Penisagenesie. Weibliche Geschlechtszuweisung unter psychotherapeutischer Betreuung der Eltern. DTSCH MED WOCHENSCHR 99: 2166-2172.
169. Prader, A. (1954): Der Genitalbefund beim Pseudohermaphroditismus femininus des kongenitalen adrenogenitalen Syndroms. HELV PAED ACTA 9: 231-247.
170. Price, P.; Wass, J.A.; Griffin, J.E.; Leshin, M.; Savage, M.O.; Large, D.M.; Bu'Lock, D.E.; Anderson, D.C.; Wilson, J.D.; Besser, G.M. (1984): High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. J CLIN INVEST 74: 1496-508.
171. Quigley, C.A. (2002): Editorial: The postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. Comment on Bouvattier et al., 2002. J CLIN ENDOCRINOL METAB 87: 24-8.
172. Quigley, C.A.; De Bellis, A.; Marschke, K.B.; el-Awady, M.K.; Wilson, E.M.; French, F.S. (1995): Androgen receptor defects: historical, clinical, and molecular perspectives. ENDOCR REV 16:271-321.
173. Raboch, J.; Kobilkova, J.; Horejsi, J.; Starka, L.; Raboch, J. (1987): Sexual development and life of women with gonadal dysgenesis. J SEX MARITAL THER 13: 117-27.
174. Ramani, P.; Yeung, C.K.; Habeebu, S.S. (1993): Testicular intratubular germ cell neoplasia in children and adolescents with intersex, AM J SURG PATHOL 17: 1124-1133.
175. Reilly, J.M.; Woodhouse, C.R. (1989): Small penis and the male sexual role. J UROL 142:569-71; discussion 572.
176. Reiner W.G. (1999): Assignment of sex in neonates with ambiguous genitalia. CURR OPIN PEDIATR 11: 363-5.
177. Reiner, W.G. (1997a): Sex assignment in the neonate with intersex or inadequate genitalia. ARCH PEDIATR ADOLESC MED 151: 1044-1045.
178. Reiner, W.G. (1997b): To be male or female - that is the question. ARCH PEDIATR ADOLESC MED 151: 224-225.
179. Reiner, W.G. (2004): Mixed-method research for child outcomes in intersex conditions. BJU INT 93 (Suppl. 3): 51-53.
180. Reiner, W.G.; Gearhart, J.P. (2004) Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth. NEW ENGL J MED 350: 333-341.
181. Richter-Unruh, A. (2005): Leydigzell-Hypoplasie und Testotoxikose - wenig bekannte Krankeitsbilder. DTSCH ARZTEBL 102: A 673-678.
182. Richter-Unruh, A.; Korsch, E.; Hiort, O.; Holterhus, P.M.; Themmen, A.P.; Wudy, S.A. (2005): Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis. EUR J ENDOCRINOL 152: 255-9.
183. Rohatgi, M.; Gupta, D.K.; Menon, P.S.; Verma, I.C.; Mathur, M. (1992): Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism - a critical analysis. INDIAN J PEDIATR 59: 487-500.
184. Ropke, A.; Pelz, AF.; Volleth, M.; Schlosser, HW.; Morlot, S.; Wieacker, PF. (2004): Sex chromosomal mosaicism in the gonads of patients with gonadal dysgenesis, but normal female or male karyotypes in lymphocytes. AM J OBSTET GYNECOL 190: 1059-62.
185. Rösler, A.; Belanger, A.; Labrie, F. (1992): Mechanisms of androgen production in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency. J CLIN ENDOCRINOL METAB 75: 773-8.
186. Rösler, A.; Kohn, G. (1983): Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role. J STEROID BIOCHEM 19: 663-74.
187. Rösler, A.; Silverstein, S.; Abeliovich, D. (1996): A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J CLIN ENDOCRINOL METAB 81: 1827-31.
188. Santti, R.; Makela, S.; Strauss, L.; Korkman, J.; Kostian, M.L. (1998): Phytoestrogens: potential endocrine disrupters in males. TOXICOL IND HEALTH 14: 223-37.
189. Sapunar, J.; Vidal, T., Bauer, K. (2003): Abnormalities of adrenal steroidogenesis in Chilean boys with micropenis. REV MED CHIL 131:46-54.
190. Savage, M.O.; Preece, M.A.; Jeffcoate, S.L.; Ransley, P.G.; Rumsby, G.; Mansfield, M.D.; Williams, D.I. (1980): Familial male pseudohermaphroditism due to deficiency of 5 alpha-reductase. CLIN ENDOCRINOL (Oxf) 12: 397-406.
191. Sax, L. (2002) How common is intersex? A reply to Anne Fausto-Sterling. J SEX RES 39: 174-178.
192. Scherer, G.; Held, M.; Erdel, M.; Meschede, D.; Horst, J.; Lesniewicz, R.; Midro, A.T. (1998): Three novel SRY mutations in XY gonadal dysgenesis and the enigma of XY gonadal dysgenesis cases without SRY mutations. CYTOGENET CELL GENET 80: 188-192.
193. Schober, J.M. (1999): A surgeon's response to the intersex controversy. In: Dreger, A. (ed.) Intersex in the Age of Ethics. Hagerstown Maryland: University Publishing Group. (161-168).
194. Schober, J.M. (2004): Feminizing genitoplasty: A synopsis of issues relating to genital surgery in intersex individuals. J PEDIATR ENDOCRINOL METAB 17: 697-703.
195. Schober, J.M.; Carmichael, P.A.; Hines, M.; Ransley, P.O. (2002): The ultimate challenge of cloacal exstrophy. J UROLOGY 167: 300-304.
196. Shah, A.A.; Shah, A.V. (2003): Neonatal genital reconstruction in penile agenesis by anterior sagittal anorectovaginourethioplasty. PEDIATR SURG INT 19: 689-692.
197. Silver, R.I.; Russell, D.W. (1999): 5alpha-reductase type 2 mutations are present in some boys with isolated hypospadias. J UROL 162: 1142-5.
198. Simpson, J.L.; Ljungqvist, A.; Ferguson-Smith, M.A.; de la Chappelle, A.; Elsas, L.J.; Ehrhardt, A.A.; Genel, M.; Ferris, E.; Carlson, A.S. (2000): Gender verification in the Olympics. JAMA 284: 1568-1569.
199. Sinnecker, G.H.G. (1999): Störungen der Keimdrüsen und der sexuellen Entwicklung. In: Kruse, K. (Hrsg.): Pädiatrische Endokrinologie. Stuttgart: Thieme, 2. Aufl.: 167-226.
200. Slijper, F.M.; Frets, P.G.; Boehmer, A.L.; Drop, S.L.; Niermeijer, M.F. (2000): Androgen insensitivity syndrome: Emotional reactions of parents and adult patients to the clinical diagnosis of AIS and its confirmation by androgen receptor gene mutation analysis. HORM RES 53: 9-15.
201. Slijper, F.M.E.; Drop, S.L.S.; Molenaar, J.C.; de Muinck Keizer-Schrama, S.M.P.F. (1998): Long-term psychological evaluation of intersex children. ARCH SEX BEHAV 27: 125-144.
202. Sobel, V.; Imperato-McGinley, I. (2004): Gender identity in XY intersexuality. CHILD ADOLESC PSYCHIATR CLIN N AM 13: 609-22.
203. Soule, S.G.; Conway, G.; Prelevic, G.M.; Prentice, M.; Ginsburg, J.; Jacobs, H.S. (1995): Osteopenia as a feature of the androgen insensitivity syndrome. CLIN ENDOCRINOL (Oxf). 43(6): 671-5.
204. Sripathi, V.; Ahmed, S.; Sakati, N.; al-Ashwal, A. (1997): Gender reversal in 46XX congenital virilizing adrenal hyperplasia (CAH). BR J UROL 79: 785-9.
205. Stein, M.T. (2003): A newborn infant with a disorder of sexual differentiation. J DEV BEHAV PEDIATR 24: 115-119.
206. Sultan, C.; Balaguer, P.; Terouanne, B.; Georget, V.; Paris, F.; Jeandel, C.; Lumbroso, S.; Nicolas, I. (2001): Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation. MOL CELL ENDOCRINOL 178: 99-105.
207. Sultan, C.; Lumbroso, S.; Paris, F.; Jeandel, C.; Terouanne, B.; Belon, C.; Audran, F.; Poujol, N.; Georget, V.; Gobinet, J.; Jalaguier, S.; Auzou, G.; Nicolas, JC. (2002): Disorders of androgen action. SEMIN REPROD MED 20: 217-28.
208. Telvi, L.; Lebbar, A.; Del Pino, O.; Barbet, J.P.; Chaussain, J.L. (1999): 45,X;46,XY mosaicism: report of 27 cases. PEDIATRICS 104: 304-8.
209. Thomas, D.F.M. (2004): Gender assignment: background and current controversies. BJU INT 93 (Suppl. 3): 47-50.
210. Tincello, D.G.; Saunders, P.T.; Hodgins, M.B.; Simpson, N.B.; Edwards, C.R.; Hargreaves, T.B.; Wu, F.C. (1997): Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome. CLIN ENDOCRINOL (Oxf) 46: 497-506.
211. Toppari, J. (2002): Environmental endocrine disrupters and disorders of sexual differentiation. SEMIN REPROD MED 20: 305-12.
212. Trobs, R.B.; Hoepffner, W; Buhligen, U.; Limbach, A.; Keller, E.; Schutz, A.; Horn, LC.; Kiess, W.; Bennek, I. (2004): Video-assisted gonadectomy in children with Ullrich Turner syndrome or 46,XY gonadal dysgenesis. EUR J PEDIATR SURG 14: 179-84.
213. Verp, M.S.; Simpson, I.L. (1987): Abnormal sexual differentiation and neoplasia. CANC GENET CYTOGENET 25: 191-218.
214. Vilchis, F.; Mendez, J.P.; Canto, P.; Lieberman, E.; Chavez, B. (2000): Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. CLIN ENDOCRINOL (Oxf) 52: 383-7.
215. Wacke, A. (1989): Vom Hermaphroditismus zum Transsexuellen. In: Eyrich, H.; Odersky, W.; Sacker, F. (Hrsg.) Festschrift für Kurt Rebmann zum 65. Gebunstag. München: Beck: 861-903.
216. Warne, G.L. (1998): Advances and challenges with intersex disorders. REPROD FERTIL DEV 10: 79-85.
217. Weidemann, W.; Linck, B.; Haupt, H.; Mentrup, B.; Romalo, G.; Stockklauser, K.; Brinkmann, A.O.; Schweikert, H.U.; Spindler, K.D. (1996): Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. CLIN ENDOCRINOL (Oxf) 45: 733-9.
218. Westenfelder, M. (2004): Zum aktuellen Stand der Intersextherapie. UROLOGE [A] 43: 379-393.
219. White, P.C.; Speiser, P.W. (2000): Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. ENDOCRINE REVIEWS 21: 245-291.
220. Wieacker, P.; Flecken, U.; Breckwoldt, M. (1992): Ein Fall von pseudovaginaler, perineoskrotaler Hypospadie mit 5alpha-Reduktase Defizienz. GEBURTSH & FRAUENHEILKDE 52: 126-128.
221. Wilson, J.D. (1999): The role of androgens in male gender role behavior. ENDOCRINE REV 20: 726-737.
222. Wilson, J.D.; Griffin, J.E.; Russell, D.W. (1993): Steroid 5 alpha-reductase 2 deficiency. ENDOCR REV 14: 577-93.
223. Wisniewski, A.B.; Migeon, C.J. (2002): Long-term perspectives for 46, XY patients affected by complete androgen insensitivity syndrome or congenital micropenis. SEMIN REPROD MED 20: 297-304.
224. Wisniewski, A.B.; Migeon, C.J.; Gearhart, J.P.; Rock, J.A.; Berkovitz, G.D.; Plotnick, L.P.; Meyer-Bahlburg, H.F.L.; Money, J. (2001): Congenital micropenis: Long-term medical, surgical, and psychosexual follow-up of individuals raised male or female. HORM RES 56: 3-11.
225. Wisniewski, A.B.; Migeon, C.J.; Malouf, M.A.; Gearhart, J.P. (2004): Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J UROL 171: 2497-501.
226. Wisniewski, A.B.; Migeon, C.J.; Meyer-Bahlburg, H.F.L.; Gearhart, J.P.; Berkovitz, G.D.; Brown, T.R.; Money, J. (2000): Complete androgen insensitivity syndrome (cAIS): Long-term medical, surgical, and psychosexual outcome. J CLIN ENDOCRINOL METABOLOL 85: 2664-2669.
227. Woelfle, J.; Hoepffner, W.; Sippell, W.G.; Bramswig, J.H.; Heidemann, P.; Deiss, D.; Bokenkamp, A.; Roth, C.; Irle, U.; Wollmann, H.A.; Zachmann, M.; Kubini, K.; Albers, N. (2002): Complete virilization in congenital adrenal hyperplasia: clinical course, medical management and disease-related complications. CLIN ENDOCRINOL (Oxf) 56: 231-8.
228. Zderic, S.A.; Canning, D.A.; Carr, M.C.; Snyder, H.M. (Eds.) (2002): Pediatric gender reassignment. A critical reappraisal. ADV EXP MED BIOL, Vol. 511.
229. Zucker, K.J. (1996): Commentary to M. Diamond: Prenatal predispositions and the clinical management of some pediatric conditions. J SEX MARITAL THER 22: 148-160.
230. Zucker, K.J.; Bradley, S.J.; Oliver, G.; Blake, J.; Fleming, S.; Hood, J, (1996): Psychosexual development of women with congenital adrenal hyperplasia [CAH]. HORMONES & BEHAVIOR 30: 300-318.